COMMUNIQUÉS West-GlobeNewswire

Immuneering to Participate in Upcoming Investor Conferences
03/09/2026
NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, today announced that [...]
Pasithea Therapeutics Announces Participation in Two September 2026 Investor Conferences
03/09/2026
-- Company will hold one-on-one investor meetings at the 12th Annual Cantor Global Healthcare Conference (September 9-11) and will present at the H.C. Wainwright 28th Annual Global Investment Conference (September 14-16 [...]
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
03/09/2026
CAMBRIDGE, Mass., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focused on advancing next-generation medicines in immunology and inflammation, [...]
Connect Biopharma to Present at the H.C. Wainwright 28th Annual Global Investment Conference
03/09/2026
SAN DIEGO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect or the Company), a clinical-stage biopharmaceutical company focused on transforming care for [...]
Agomab to Participate in Upcoming Investor Conferences
03/09/2026
Antwerp, Belgium, September 3, 2026 – Agomab Therapeutics NV (Nasdaq: AGMB) (“Agomab”), a clinical-stage biopharmaceutical company focused on fibro-inflammation, today announced that members of the management team will [...]
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/09/2026
NAARDEN, The Netherlands and MIAMI, Sept. 03, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral [...]
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/09/2026
BOSTON, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced that [...]
Xenon to Present at Wells Fargo Healthcare Conference
03/09/2026
VANCOUVER, BC and BOSTON, MA, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and [...]
Rein Therapeutics to Present at Upcoming September Investor Conferences
03/09/2026
AUSTIN, Texas, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines in orphan pulmonary and fibrosis [...]
Arvinas to Participate in Upcoming Investor Conferences
03/09/2026
NEW HAVEN, Conn., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN) (“Arvinas” or the “Company”), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation [...]
Kamada Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to Shareholders
03/09/2026
REHOVOT, Israel and HOBOKEN, N.J., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (the “Company”) (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for [...]
Applied Biologics Achieves Key Preclinical Milestone in Disease-Modifying Osteoarthritis Gene Therapy Program
03/09/2026
Company demonstrates successful gene delivery and expression in human cartilage cells using internally designed gene therapy platform SCOTTSDALE, Ariz., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, a [...]
Curia célèbre l’agrandissement de son site d’Albuquerque lors d’une cérémonie d’inauguration
03/09/2026
ALBANY, New York, 03 sept. 2026 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), une organisation de premier plan à l´échelle mondiale spécialisée dans la recherche, le développement et la fabrication, a annoncé aujourd’ [...]
Curia Celebrates Expansion of Albuquerque Facility with Ribbon-Cutting Ceremony
03/09/2026
ALBANY, N.Y., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading global research, development and manufacturing organization, today announced the grand opening of its expanded campus in Albuquerque [...]
Hi Rasmus Raises $50 Million from Updata Partners to Accelerate Its Mission
03/09/2026
After growing to serve 1,000+ organizations in 90 countries without outside capital, Hi Rasmus will accelerate its next stage of growth while remaining founder-led and centered on helping care teams focus on the child [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2026
03/09/2026
Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2026 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 juillet 2026
03/09/2026
Nombre total de droits de vote et d’actions composant le capital social au 31 juillet 2026 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]
GENFIT to Host Virtual KOL Event Focused on MASH Diagnostics on September 9, 2026
03/09/2026
Presentations will highlight the clinical utility and long-term commercial opportunity of GENFIT’s proprietary NIS platform, a non-invasive diagnostic technology for MASH Lille (France), Cambridge (Massachusetts, United [...]
GENFIT organise un événement virtuel avec un leader d’opinion (KOL) consacré au diagnostic de la MASH le 9 septembre 2026
03/09/2026
Les présentations mettront en avant l’utilité clinique et le potentiel commercial à long terme de la plateforme propriétaire NIS de GENFIT, une technologie de diagnostic non invasive pour la MASH Lille (France), [...]

Pages